
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of Risk Minimization Measures to Prevent Pregnancy Exposure to Mycophenolate-Containing Medicines in Europe
Terri Madison, Barbara Donner, Roger Mutter, et al.
Pharmaceutical Medicine (2019) Vol. 33, Iss. 5, pp. 395-406
Closed Access | Times Cited: 6
Terri Madison, Barbara Donner, Roger Mutter, et al.
Pharmaceutical Medicine (2019) Vol. 33, Iss. 5, pp. 395-406
Closed Access | Times Cited: 6
Showing 6 citing articles:
Postmarket safety communications on drugs approved in Japan: A 25‐year analysis
Yusuke Tanaka, Mototsugu TANAKA, Haruna Miyazawa, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 1
Yusuke Tanaka, Mototsugu TANAKA, Haruna Miyazawa, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 1
Comment on: "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)"
Alain Braillon, Marine Martin
Drug Safety (2021) Vol. 44, Iss. 9, pp. 1007-1009
Closed Access | Times Cited: 6
Alain Braillon, Marine Martin
Drug Safety (2021) Vol. 44, Iss. 9, pp. 1007-1009
Closed Access | Times Cited: 6
Factors influencing the implementation of medicine risk communications by healthcare professionals in clinical practice: A systematic review
Amal Bandar Alharbi, Ilhem Berrou, Nkiruka Umaru, et al.
Research in Social and Administrative Pharmacy (2022) Vol. 19, Iss. 1, pp. 28-56
Open Access | Times Cited: 3
Amal Bandar Alharbi, Ilhem Berrou, Nkiruka Umaru, et al.
Research in Social and Administrative Pharmacy (2022) Vol. 19, Iss. 1, pp. 28-56
Open Access | Times Cited: 3
Vismodegib (ERIVEDGE) pregnancy prevention programme: assessment of risk awareness
Gabriel Schnetzler, Miguel Cuberos, Reinhard Bucher, et al.
Journal of Dermatological Treatment (2020) Vol. 33, Iss. 1, pp. 466-472
Closed Access | Times Cited: 1
Gabriel Schnetzler, Miguel Cuberos, Reinhard Bucher, et al.
Journal of Dermatological Treatment (2020) Vol. 33, Iss. 1, pp. 466-472
Closed Access | Times Cited: 1
Impact of a Treatment Guide on Intravenous Fluids in Minimising the Risk of Hospital-Acquired Hyponatraemia in Denmark
Per Sindahl, Christian Overgaard‐Steensen, Helle Wallach‐Kildemoes, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5105-5105
Open Access
Per Sindahl, Christian Overgaard‐Steensen, Helle Wallach‐Kildemoes, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5105-5105
Open Access
Effekt der Rote-Hand-Briefe zu Citalopram und Escitalopram auf Verordnungszahlen bei der stationären Behandlung von Angsterkrankungen
Ursula Köberle, R. Grohmann, Michael Belz, et al.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2022) Vol. 65, Iss. 11, pp. 1204-1212
Closed Access
Ursula Köberle, R. Grohmann, Michael Belz, et al.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2022) Vol. 65, Iss. 11, pp. 1204-1212
Closed Access